Hattersley Gary
CHIEF SCIENTIFIC OFFICER
Hattersley Gary has filed 3 SEC Form 4 filings (8 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Aug 21, 2026.
On the most recent filing, Hattersley Gary is listed as CHIEF SCIENTIFIC OFFICER at Nuvation Bio Inc. Inside the rolling window, Hattersley Gary reported no open-market purchases and 3 open-market sales totaling $3.9M in NUVB. The largest disclosed transaction in the window is a sale of 369,051 NUVB shares on Nov 20, 2025, worth $2.7M.
Companies traded
Other insiders at NUVB
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.9M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Hattersley Gary made?
Hattersley Gary has filed 3 SEC Form 4 filings (8 transaction rows) across 1 company since 2025.
Which companies does Hattersley Gary trade?
Hattersley Gary has filed SEC Form 4 disclosures for 1 company, including NUVB.
When was Hattersley Gary's most recent SEC Form 4 filing?
Hattersley Gary's most recent SEC Form 4 filing on Tracefour is dated Aug 21, 2026.
What is Hattersley Gary's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Hattersley Gary is listed as CHIEF SCIENTIFIC OFFICER.
What is Hattersley Gary's total buy and sell value in the current window?
Inside the rolling retention window, Hattersley Gary bought $0 and sold $3.9M based on SEC Form 4 filings.
What was Hattersley Gary's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 369,051 NUVB shares on 2025-11-20, worth $2.7M, per SEC Form 4 filings.